May 22th, 2023 (Shanghai) — We are glad to announce that Dr. Ying Niu, the China Search and Evaluation Lead of Pfizer, has been invited as a keynote speaker at ACCESS CHINA Boston Forum on June 4th. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About the speaker
Dr. Ying Niu works as China Search and Evaluation Lead at Pfizer Worldwide Business Development (WWBD) department with a focus on mutual beneficial partnership with China innovative bio-techs.
Dr. Ying has over ten-year experience in the pharmaceuticals industry. She joined Pfizer in 2011 after working in consulting and has worked in multiple departments and positions at Pfizer. During her career she has experience in working across several therapeutic areas -oncology, Inflammation and immunology, Pain, CNS, Urology and anti-infectives. Before joining WWBD, she led the evaluation, new product development and market launch for Pfizer in-house pipeline assets. Dr. Ying previously involved clinical development and pre-launch preparations for Ibrance, Staquis and multiple other products.
Dr. Ying received her Ph.D. in Biology from Tsinghua University.
专家简介：
牛颖博士供职于辉瑞全球业务开发部，担任中国搜索与评估负责人，专注于与中国创新型医药企业的合作共赢。
牛颖博士具有十余年生物医药产业经验。她于2011年离开咨询业加入辉瑞，曾供职于辉瑞的多个部门与岗位。其负责的治疗领域涵盖肿瘤、炎症与免疫、疼痛、中枢神经、泌尿、抗感染等。在加入全球业务开发部之前，她负责辉瑞内部产品线的评估、新产品开发与上市等工作。曾参与爱博新Ibrance，舒坦明Staquis等多个产品的临床开发与上市准备工作。
牛颖毕业于清华大学生物系，拥有生物学博士学位。
About ACCESS CHINA Boston Forum
“ACCESS CHINA – Boston Forum @BIO” is scheduled to be held on June 4th and June 13th-15th, 2023, in Boston and online, respectively. This event is expected to be the largest Asia-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”. During the forum, we will cover a range of key topics include drug innovation, market trends, partnership models, and best practices for successful collaborations, etc.
Conference Name: ACCESS CHINA – Boston Forum @BIO
Date & Time: June 4, Sun. (Boston) and June 13-15 (Online)
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 1000 participants Online, 150 participants onsite; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs, investors.
View more information at https://biotochina.org/
关于药通中国-波士顿论坛
“ACCESS CHINA 药通中国-波士顿论坛@BIO”将于2023年6月4-15日在波士顿及线上举行的。此次论坛将是BIO Convention 2023大会期间最大的亚洲主题交流活动。在过去3年时间，药通中国已成功举办13届线上线下活动，帮助近千家公司在药通平台上展出。
大会名称：药通中国-波士顿论坛@BIO
大会日期：2023.6.4（周日，波士顿） 2023.6.13-15（线上）
大会内容：主题演讲、圆桌讨论、海内外优质项目路演、睿智医药-药通中国招待晚宴
大会规模：预计线上1000参会者； 线下150参会者; 100场公司路演
参会观众：海内外医药企业（药企及Biotech）高管及BD、基金高管
查看更多信息： https://biotochina.org/
MORE INFORMATION
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 